We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$1.01B
AUM Growth
+$295M
Cap. Flow
+$295M
Cap. Flow %
29.1%
Top 10 Hldgs %
13.6%
Holding
464
New
106
Increased
170
Reduced
65
Closed
115

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
2
IBM icon
IBM
IBM
+$9.84M
3
BIIB icon
Biogen
BIIB
+$9.71M
4
EBAY icon
eBay
EBAY
+$9.47M
5
AAPL icon
Apple
AAPL
+$8.36M

Sector Composition

Rank Sector Weight
1 Financials 15.35%
2 Healthcare 14.47%
3 Technology 13.09%
4 Consumer Discretionary 12.23%
5 Industrials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
326
PepsiCo
PEP
$189B
$300K 0.03%
3,213
-43
-1% -$4.11K
GS icon
327
Goldman Sachs
GS
$303B
$290K 0.03%
1,390
-13
-0.9% -$2.65K
AMZN icon
328
Amazon
AMZN
$2.98T
$283K 0.03%
13,020
-1,000
-7% -$20.9K
ABB
329
DELISTED
ABB Ltd
ABB
$272K 0.03%
13,007
-1,374
-10% -$30.2K
HSBC icon
330
HSBC
HSBC
$356B
$264K 0.03%
6,605
+933
+16% +$38.9K
DIS icon
331
Walt Disney
DIS
$181B
$257K 0.03%
2,250
-11,282
-83% -$1.24M
KO icon
332
Coca-Cola
KO
$373B
$255K 0.03%
6,512
-162
-2% -$6.59K
CHSP
333
DELISTED
Chesapeake Lodging Trust
CHSP
$243K 0.02%
7,957
-143,829
-95% -$4.55M
PCRX icon
334
Pacira BioSciences
PCRX
$1.01B
$241K 0.02%
3,406
-5,534
-62% -$436K
MCK icon
335
McKesson
MCK
$103B
$239K 0.02%
1,061
-6
-0.6% -$1.39K
BUD icon
336
AB InBev
BUD
$166B
$222K 0.02%
1,836
-406
-18% -$49.8K
GM icon
337
General Motors
GM
$76.3B
$222K 0.02%
6,651
-29,895
-82% -$1.07M
COST icon
338
Costco
COST
$420B
$210K 0.02%
1,552
-8
-0.5% -$1.15K
UBS icon
339
UBS Group
UBS
$176B
$201K 0.02%
9,458
-2,002
-17% -$41.8K
USB icon
340
US Bancorp
USB
$99.5B
$200K 0.02%
4,610
-52
-1% -$2.27K
MUFG icon
341
Mitsubishi UFJ Financial
MUFG
$253B
$156K 0.02%
21,588
-6,665
-24% -$47.5K
SAN icon
342
Banco Santander
SAN
$212B
$148K 0.01%
22,279
-524
-2% -$3.65K
LYG icon
343
Lloyds Banking Group
LYG
$91.3B
$135K 0.01%
24,916
-6,737
-21% -$35.1K
SMFG icon
344
Sumitomo Mitsui Financial
SMFG
$163B
$98K 0.01%
10,971
-3,299
-23% -$28.6K
ABEV icon
345
Ambev
ABEV
$46.7B
$88K 0.01%
14,475
-804
-5% -$4.97K
MFG icon
346
Mizuho Financial
MFG
$130B
$81K 0.01%
18,685
+1,045
+6% +$4.19K
NMR icon
347
Nomura Holdings
NMR
$29B
$73K 0.01%
10,825
-2,161
-17% -$14.1K
ABG icon
348
Asbury Automotive
ABG
$3.88B
-46,021
Closed -$3.82M
AGX icon
349
Argan
AGX
$8.26B
-41,647
Closed -$1.51M
AMKR icon
350
Amkor Technology
AMKR
$13.5B
-218,030
Closed -$1.93M

Similar funds

Convergence Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Convergence Investment Partners held 464 positions worth $1.01B, up 41% from $720M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Convergence Investment Partners deployed $295M of net new capital in Q2 2015, opening 106 new positions and adding to 170 existing holdings. Its largest new stake was Biogen: 24,201 shares worth $9.78M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Wells Fargo, an estimated $4.75M trimmed.

  • Convergence Investment Partners's largest Q2 2015 buy was Biogen: 24,201 shares worth $9.78M.
  • Convergence Investment Partners added most to Alphabet (Google) Class C in Q2 2015, an estimated $10.8M increase.
  • Convergence Investment Partners's biggest Q2 2015 reduction was Wells Fargo, cutting an estimated $4.75M.
  • Convergence Investment Partners fully exited Wellcare Health Plans, Inc. in Q2 2015, selling an estimated $5.02M.
  • Convergence Investment Partners's ten largest holdings make up 14% of its $1.01B portfolio in Q2 2015.
  • Convergence Investment Partners opened 106 new positions and closed 115 in Q2 2015.
  • Convergence Investment Partners's portfolio value rose 41% quarter-over-quarter to $1.01B.

Based on Convergence Investment Partners's 13F filing for Q2 2015, filed 5 Aug 2015.